Cargando…
Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655562/ https://www.ncbi.nlm.nih.gov/pubmed/29094071 http://dx.doi.org/10.1002/lio2.78 |
_version_ | 1783273553853939712 |
---|---|
author | Virgin, Frank W. |
author_facet | Virgin, Frank W. |
author_sort | Virgin, Frank W. |
collection | PubMed |
description | OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with chronic rhinosinusitis (CRS) in the non‐CF patient population. However, the impact of CRS on the pediatric CF population remains uncertain. The purpose of this article is to review the current state of outcome measures for CRS in pediatric CF patients. DATA SOURCES: PubMed and EMBASE literature review METHODS: PubMed and EMBASE electronic databases were searched using Boolean searches that incorporated mesh headings and plain language for quality of life, symptom evaluation, pediatric patients, and sinusitis/rhinosinusitis. Studies were included if the study primarily evaluated a pediatric Cystic Fibrosis‐Chronic Rhinosinusitis (CF‐CRS) population and the primary outcome measure was quality of life evaluation. RESULTS: The search yielded 34 unique articles. A total of 7 articles met inclusion criteria CONCLUSIONS: Despite the high frequency of chronic rhinosinusitis in the pediatric CF patient population, its impact on quality of life is not well understood. Currently there is a lack of a validated disease specific quality of life instruments available to assess the impact of CRS on the pediatric CF patient population. LEVEL OF EVIDENCE: 5. |
format | Online Article Text |
id | pubmed-5655562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56555622017-11-01 Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis Virgin, Frank W. Laryngoscope Investig Otolaryngol Allergy, Rhinology, and Immunology OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with chronic rhinosinusitis (CRS) in the non‐CF patient population. However, the impact of CRS on the pediatric CF population remains uncertain. The purpose of this article is to review the current state of outcome measures for CRS in pediatric CF patients. DATA SOURCES: PubMed and EMBASE literature review METHODS: PubMed and EMBASE electronic databases were searched using Boolean searches that incorporated mesh headings and plain language for quality of life, symptom evaluation, pediatric patients, and sinusitis/rhinosinusitis. Studies were included if the study primarily evaluated a pediatric Cystic Fibrosis‐Chronic Rhinosinusitis (CF‐CRS) population and the primary outcome measure was quality of life evaluation. RESULTS: The search yielded 34 unique articles. A total of 7 articles met inclusion criteria CONCLUSIONS: Despite the high frequency of chronic rhinosinusitis in the pediatric CF patient population, its impact on quality of life is not well understood. Currently there is a lack of a validated disease specific quality of life instruments available to assess the impact of CRS on the pediatric CF patient population. LEVEL OF EVIDENCE: 5. John Wiley and Sons Inc. 2017-05-31 /pmc/articles/PMC5655562/ /pubmed/29094071 http://dx.doi.org/10.1002/lio2.78 Text en © 2017 The Authors Laryngoscope Investigative Otolaryngology published by Wiley Periodicals, Inc. on behalf of The Triological Society This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Allergy, Rhinology, and Immunology Virgin, Frank W. Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title | Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title_full | Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title_fullStr | Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title_full_unstemmed | Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title_short | Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
title_sort | clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis |
topic | Allergy, Rhinology, and Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655562/ https://www.ncbi.nlm.nih.gov/pubmed/29094071 http://dx.doi.org/10.1002/lio2.78 |
work_keys_str_mv | AT virginfrankw clinicalchronicrhinosinusitisoutcomesinpediatricpatientswithcysticfibrosis |